Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Dinkova-Kostova, P. Talalay (2010)
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector.Archives of biochemistry and biophysics, 501 1
C. Haagsma, P. Riel, D. ROOIJ, T. Vree, F. Russel, M. HOF, L. Putte (1994)
Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.British journal of rheumatology, 33 11
J. H. Hurley (2008)
ESCRT complexes and the biogenesis of multivesicular bodiesBiochem. Pharmacol., 20
M. Yao, Xingguang Liu, Dong Li, Taoyong Chen, Z. Cai, Xuetao Cao (2009)
Late Endosome/Lysosome-Localized Rab7b Suppresses TLR9-Initiated Proinflammatory Cytokine and Type I IFN Production in Macrophages1The Journal of Immunology, 183
T. Yamazaki, Takashi Yokoyama, H. Akatsu, T. Tukiyama, T. Tokiwa (2003)
Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasoneIn Vitro Cellular & Developmental Biology - Animal, 39
M. Yao, X. Liu, D. Li, T. Chen (2009)
Late endosome/lysosome‐localized Rab7b suppresses TLR9‐initiated proinflammatory cytokine and type I IFN production in macrophagesJ. Biol. Chem., 183
M. Miettinen, I. Virtanen (1984)
Synovial sarcoma—a misnomerMicrobiol. Immunol., 117
Jae Chang, Kyu-Jae Lee, Soo-Ki Kim, D. Yoo, T. Kang (2014)
Validity of SW982 synovial cell line for studying the drugs against rheumatoid arthritis in fluvastatin-induced apoptosis signaling modelThe Indian Journal of Medical Research, 139
T. Yamazaki, T. Yokoyama, H. Akatsu, T. Tukiyama (2003)
Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasoneIndian J. Med. Res., 39
J. Hurley (2008)
ESCRT complexes and the biogenesis of multivesicular bodies.Current opinion in cell biology, 20 1
Sonoko Shimada, Manabu Nakamura, Yasuhiko Tanaka, K. Tsutsumi, Masayo Katano, K. Masuko, K. Yudoh, I. Koizuka, Tomohiro Kato (2007)
CrossLinking of the CD69 Molecule Enhances S100A9 Production in Activated NeutrophilsMicrobiology and Immunology, 51
M. Fujiwara, K. Mitsui, I. Yamamoto (1990)
Inhibition of proliferative responses and interleukin 2 productions by salazosulfapyridine and its metabolites.Japanese journal of pharmacology, 54 2
E. H. Choy, G. S. Panayi (2001)
Cytokine pathways and joint inflammation in rheumatoid arthritisCurr. Opin. Cell Biol., 344
V. Linares, V. Alonso, J. L. Domingo (2011)
Oxidative stress as a mechanism underlying sulfasalazine‐induced toxicityAm. J. Pathol, 10
U. Oleksiewicz, T. Liloglou, J. K. Field, G. Xinarianos (2011)
Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin familyJ. Biol., 68
J. Wessels, T. Huizinga, H. Guchelaar (2007)
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis.Rheumatology, 47 3
C. Bucci, O. Bakke, C. Progida (2010)
Rab7b and receptors traffickingCommunicative & Integrative Biology, 3
Xiaoying Qiao, D. Pham, Hongyu Luo, Jiangping Wu (2009)
Ran Overexpression Leads to Diminished T Cell Responses and Selectively Modulates Nuclear Levels of c-Jun and c-Fos*The Journal of Biological Chemistry, 285
M. Ralser, M. M. Wamelink, A. Kowald, B. Gerisch (2007)
Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stressArch. Biochem. Biophys., 6
(2002)
ovial sarcoma lacks synovial differentiation
M. Miettinen, I. Virtanen (1984)
Synovial sarcoma--a misnomer.The American journal of pathology, 117 1
C. Fletcher, K. Unni, F. Mertens (2002)
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
M. Ralser, M. Wamelink, A. Kowald, Birgit Gerisch, G. Heeren, E. Struys, E. Klipp, C. Jakobs, M. Breitenbach, H. Lehrach, S. Krobitsch (2007)
Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stressJournal of Biology, 6
Huang-Ge Zhang, Cunren Liu, K. Su, Shaohua Yu, Liming Zhang, Shuangqin Zhang, Jianhua Wang, Xu Cao, W. Grizzle, R. Kimberly (2006)
A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death.Journal of immunology, 176 12
D. Taylor, Ç. Gerçel-Taylor (2011)
Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironmentsSeminars in Immunopathology, 33
A. Liu, B. Feng, W. Gu, X. Cheng (2013)
The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem‐like characteristicsAm. J. Pathol., 42
R. Simpson, S. Jensen, Justin Lim (2008)
Proteomic profiling of exosomes: Current perspectivesPROTEOMICS, 8
A. Nishiyama, M. Matsui, S. Iwata, K. Hirota, H. Masutani, Hajime Nakamura, Y. Takagi, H. Sono, Y. Gon, J. Yodoi (1999)
Identification of Thioredoxin-binding Protein-2/Vitamin D3 Up-regulated Protein 1 as a Negative Regulator of Thioredoxin Function and Expression*The Journal of Biological Chemistry, 274
M. Record, C. Subra, S. Silvente-Poirot, M. Poirot (2011)
Exosomes as intercellular signalosomes and pharmacological effectors.Biochemical pharmacology, 81 10
Huang-Ge Zhang, Cunren Liu, Kaihun Su, Shaohua Yu, Liming Zhang, Shuangqin Zhang, Jianhua Wang, Xu Cao, W. Grizzle, R. Kimberly (2006)
A Membrane Form of TNF-α Presented by Exosomes Delays T Cell Activation-Induced Cell Death1The Journal of Immunology, 176
H. Aono, T. Hasunuma, K. Fujisawa, T. Nakajima, K. Yamamoto, S. Mita, K. Nishioka (1996)
Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine.The Journal of rheumatology, 23 1
Yuzhen Wang, Taoyong Chen, Chaofeng Han, D. He, Haibo Liu, Huazhang An, Z. Cai, Xuetao Cao (2007)
Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4.Blood, 110 3
R. Roncagalli, J. E. Taylor, S. Zhang, X. Shi (2005)
Negative regulation of natural killer cell function by EAT‐2, a SAP‐related adaptorCell Mol. Life Sci., 6
Urszula Oleksiewicz, T. Liloglou, J. Field, G. Xinarianos (2011)
Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin familyCellular and Molecular Life Sciences, 68
S. Poon, S. Easterbrook-Smith, M. Rybchyn, J. Carver, M. Wilson (2000)
Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state.Biochemistry, 39 51
(2000)
Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface
S. Nagayama, T. Katagiri, T. Tsunoda, Taisuke Hosaka, Y. Nakashima, N. Araki, K. Kusuzaki, T. Nakayama, T. Tsuboyama, Takashi Nakamura, M. Imamura, Yusuke Nakamura, J. Toguchida (2002)
Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray.Cancer research, 62 20
S. Shimada, M. Nakamura, Y. Tanaka, K. Tsutsumi (2007)
Crosslinking of the CD69 molecule enhances S100A9 production in activated neutrophilsN. Engl. J. Med., 51
M. Smith, C. Fisher, L. Wilkinson, J. Edwards (1995)
Synovial sarcomas lack synovial differentiationHistopathology, 26
Tomohiro Kato, S. Miyaki, H. Ishitobi, Yoshihiro Nakamura, T. Nakasa, M. Lotz, M. Ochi (2014)
Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytesArthritis Research & Therapy, 16
G. Raposo, H. Nijman, W. Stoorvogel, R. Liejendekker, C. Harding, C. Melief, H. Geuze (1996)
B lymphocytes secrete antigen-presenting vesiclesThe Journal of Experimental Medicine, 183
E. Choy, G. Panayi (2001)
Cytokine pathways and joint inflammation in rheumatoid arthritis.The New England journal of medicine, 344 12
(1995)
Synovial sarcoma lacks synovial differentiation
(2001)
Antiinflammatory mechanisms of methotrexate in rhematoid arthritis
M. Cutolo, A. Sulli, C. Pizzorni, B. Seriolo, R. Straub (2001)
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritisAnnals of the Rheumatic Diseases, 60
Romain Roncagalli, James Taylor, Shaohua Zhang, Xiaochu Shi, Riyan Chen, M. Cruz-Munoz, L. Yin, S. Latour, A. Veillette (2005)
Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptorNature Immunology, 6
L. W. Smith (1927)
SynoviomataCancer Res., 3
R. Matasić, A. Dietz, S. Vuk-Pavlović (2001)
Maturation of human dendritic cells as sulfasalazine target.Croatian medical journal, 42 4
M. Record, C. Subra, S. Silvente‐Poirot, M. Poirot (2011)
Exosomes as intercellular signalosomes and pharmacological effectorsSemin. Immunopathol., 81
Aiguo Liu, Baohua Feng, Wenguang Gu, Xiangyang Cheng, Tiejun Tong, Hongzhi Zhang, Yongzhen Hu (2013)
The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.International journal of oncology, 42 4
Du Feng, Wen-long Zhao, Y. Ye, X. Bai, Rui-Qin Liu, Lei-fu Chang, Qiang Zhou, Sen‐fang Sui (2010)
Cellular Internalization of Exosomes Occurs Through PhagocytosisTraffic, 11
V. Linares, Virginia Alonso, J. Domingo (2011)
Oxidative stress as a mechanism underlying sulfasalazine-induced toxicityExpert Opinion on Drug Safety, 10
X. Qiao, D. N. Pham, H. Luo, J. Wu (2010)
Ran overexpression leads to diminished T cell responses and selectively modulates nuclear levels of c‐Jun and c‐FosNat. Immunol., 285
A. Clayton, J. Mitchell, J. Court, M. Mason, Z. Tabi (2007)
Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.Cancer research, 67 15
H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, James Lee, J. Lötvall (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 9
C. Théry, L. Zitvogel, S. Amigorena (2002)
Exosomes: composition, biogenesis and functionNature Reviews Immunology, 2
A. Nishiyama, M. Matsui, S. Iwata, K. Hirota (1999)
Identification of thioredoxin‐binding protein‐2/vitamin D(3) up‐regulated protein 1 as a negative regulator of thioredoxin function and expressionCommun. Integr. Biol., 274
Purpose To elucidate effects of salazosulfapyridine (SASP) and methotrexate (MTX), major anti‐rheumatic drugs, on exosomes derived from SW982 of a human synovial sarcoma cell line. Experimental design SW982 was treated with SASP and/or MTX under interleukin‐1β (IL‐1β)‐treated or nontreated conditions. Exosomes were isolated from the culture media, and exosomal proteome was analyzed by 2D‐DIGE. Protein spots whose intensity was significantly altered by the above treatments were identified by MS. Results Two hundred ninety‐four protein spots were detected in the exosome preparations by 2D‐DIGE. Compared to the nontreated cells, SASP‐, MTX‐, and (SASP + MTX)‐treated cells displayed 8, 10, and 21 exosomal protein spots with more than ±2.0‐fold intensity differences (p < 0.05), respectively. Similarly, the IL‐1β‐treated cells displayed 58 exosomal protein spots with more than ±1.5‐fold intensity differences (p < 0.05). In about half of the 58 spots, the IL‐1β‐induced intensity changes were suppressed by simultaneous addition of SASP and/or MTX. Most of the identified proteins were immunity‐ or anti‐oxidation‐related proteins. Conclusions and clinical relevance The SASP and/or MTX treatments altered the protein profiles of exosomes and suppressed the effects of IL‐1β on the exosomal proteome. Exosomes may play roles in the actions of these anti‐rheumatic drugs.
Proteomics - Clinical Applications – Wiley
Published: Feb 1, 2016
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.